Lupin

Lupin Biotech, with a new-age R&D facility in Pune, is developing and commercialising biosimilars globally. The successful…

Currently in its seventh year, the India Pharma Awards celebrates the advancements and achievements of the Indian Pharmaceutical…

With headwinds in overseas markets, it is vital for pharma companies in India to grow their presence in the domestic market. But…

Lupin’s Potassium Chloride for Oral Solution USP, 20 mEq, is the generic equivalent of Pharma Research Software Solution, LLC’s…

Under the terms of the agreement, Lupin’s subsidiary Nanomi BV will divest its entire stake (99.82 per cent) in Kyowa to Unison’s…

The award recognises individuals who have made significant and consistent contribution to teaching and research in pharmaceutical…

The company had posted net profit of Rs 288.45 crore in July-September period of 2018-19

To market a generic equivalent of LEVOXYL which is indicated for the treatment of hypothyroidism and used for pituitary…

The approval is for marketing 250 mg and 500 mg tablets

The inspection for the oral solid facility at Nagpur closed without any Form 483 observation